Evidence map›Paper›PMID 38019367›Full record

ArticleCancer causes & control : CCC2024

Accuracy of patient race and ethnicity data in a central cancer registry.

Rachel R Codden, Carol Sweeney, Blessing S Ofori-Atta, Kimberly A Herget, Kacey Wigren, Sandra Edwards, Marjorie E Carter, Rachel D McCarty, Mia Hashibe, Jennifer A Doherty and 1 more

Abstract read
In one paragraph

Article in Cancer causes & control : CCC, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rachel R CoddenDivision of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID http://orcid.org/0000-0003-2863-8826
Carol SweeneyDivision of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID http://orcid.org/0000-0003-1113-7160
Blessing S Ofori-AttaDivision of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID http://orcid.org/0009-0004-4332-3974
Kimberly A HergetUtah Cancer Registry, University of Utah, Salt Lake City, UT, USA.ORCID http://orcid.org/0000-0002-4770-3083
Kacey WigrenUtah Cancer Registry, University of Utah, Salt Lake City, UT, USA.
Sandra EdwardsDepartment of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA.
Marjorie E CarterUtah Cancer Registry, University of Utah, Salt Lake City, UT, USA.
Rachel D McCartyHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Mia HashibeUtah Cancer Registry, University of Utah, Salt Lake City, UT, USA.
Jennifer A DohertyUtah Cancer Registry, University of Utah, Salt Lake City, UT, USA.ORCID http://orcid.org/0000-0002-1454-8187
Morgan M MillarDivision of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA. Morgan.millar@hsc.utah.edu.ORCID http://orcid.org/0000-0001-5532-6970

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
CTSA Predoctoral T32 at University of Utah: Spheres of Translation Across the Research Spectrum (STARS) Training ProgramT32TR004392 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI ANGELA FAGERLIN, Keke Celeste Fairfax · 2023 to 2026
$1.3M
CDC HHS NU58DP007131NCATS NIH HHS T32 TR004392NCATS NIH HHS UL1 TR002538NCATS NIH HHS UM1 TR004409NCI NIH HHS HHSN261201800016CNCI NIH HHS HHSN261201800016I
6 · The paper itself

Abstract

purposeRace and Hispanic ethnicity data can be challenging for central cancer registries to collect. We evaluated the accuracy of the race and Hispanic ethnicity variables collected by the Utah Cancer Registry compared to self-report.

methodsParticipants were 3,162 cancer survivors who completed questionnaires administered in 2015-2022 by the Utah Cancer Registry. Each survey included separate questions collecting race and Hispanic ethnicity, respectively. Registry-collected race and Hispanic ethnicity were compared to self-reported values for the same individuals. We calculated sensitivity and specificity for each race category and Hispanic ethnicity separately.

resultsSurvey participants included 323 (10.2%) survivors identifying as Hispanic, a lower proportion Hispanic than the 12.1% in the registry Hispanic variable (sensitivity 88.2%, specificity 96.5%). For race, 43 participants (1.4%) self-identified as American Indian or Alaska Native (AIAN), 32 (1.0%) as Asian, 23 (0.7%) as Black or African American, 16 (0.5%) Pacific Islander (PI), and 2994 (94.7%) as White. The registry race variable classified a smaller proportion of survivors as members of each of these race groups except White. Sensitivity for classification of race as AIAN was 9.3%, Asian 40.6%, Black 60.9%, PI 25.0%, and specificity for each of these groups was > 99%. Sensitivity and specificity for White were 98.8% and 47.4%.

conclusionCancer registry race and Hispanic ethnicity data often did not match the individual's self-identification. Of particular concern is the high proportion of AIAN individuals whose race is misclassified. Continued attention should be directed to the accurate capture of race and ethnicity data by hospitals.

Indexed as

EthnicityNeoplasmsAmerican Indian or Alaska NativeAsianAsian American Native Hawaiian and Pacific IslanderBlack or African AmericanHispanic or LatinoHumansRegistriesUnited StatesUtahWhiteCancer disparitiesCancer registriesCancer survivorHispanic ethnicityRaceValidity

Identifiers

PMID38019367
PMCPMC10960663

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.